BPC-157 has a favorable acute safety signal in animal studies, but there are zero completed Phase III human clinical trials, so its human side-effect profile is essentially uncharacterized
da Silva PB, Machado RTA, Pironi AM, Alves RC, de Arajo PR, Dragalzew AC, Dalberto I, Chorilli M
doi:10.2147/OPTH.S80954
People who already understand this combination often prefer to explore available glutathione tablet options before reading further
DSIP should be approached with particular caution by individuals with severe psychiatric conditions, untreated sleep disorders like severe sleep apnea, or those taking medications affecting the central nervous system
Some people even use both in a balanced routine